MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Metagenomi (MGX) Ownership - Who owns Metagenomi?
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more
Profile
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
55.33M
P/E Ratio
N/A
Total Cash
274.59M
Projected Growth
N/A
Total Debt
46.07M
Revenue
55.08M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.35
Total Debt/Equity
N/A
Revenue/Share
1.58 USD as % of share price
Fundamentals
MGX
Capitalization
55.3M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
275M
Total Cash/Share
7.35
Total Debt
46.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.58%
Revenue
55.1M
ROE
N/A
Book Value
256M
P/B Ratio
0.24
Cash Flow
N/A
Earnings
-2.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
6.18
Current Revenue Per Employee
55623.19
Dividends Per Share - Security
N/A
EBITDA
-65.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.86
Shares Held By Institutions
46.3M
Shares Outstanding - Current
37.4M
Total Liabilities
103M
Total Volume MTD
N/A
Value
1
Gain YTD
-59.003
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co